Finn Patrick John 4

What Happened

• Finn Patrick John, President and COO of Twist Bioscience, disposed of 2,844 shares on 2026-05-04 at $57.15 per share, generating proceeds of $162,531. The transaction is reported as a sale (S) and was done to satisfy tax withholding obligations tied to RSU vesting — a sell-to-cover rather than a discretionary open-market trade.

Key Details

• Transaction date and price: 2026-05-04 at $57.15 per share
• Total proceeds: $162,531 (2,844 shares × $57.15)
• Reason/footnote: Sell-to-cover to satisfy tax withholding on vested Restricted Stock Units (per filing footnote F1); not a discretionary sale by the insider
• Filing date: 2026-05-06 (filed two days after the transaction), which appears timely under Form 4 rules
• Shares owned after the transaction: Not provided in the summary data supplied

Context

• Sell-to-cover transactions are common when restricted stock units vest; the company or insider arranges a sale of just enough shares to pay required taxes. These transactions typically do not signal the insider’s view of the company’s prospects in the same way an intentional open-market sale might.